Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
McKesson
Fuji
Johnson and Johnson
Citi
Covington
Accenture
Boehringer Ingelheim
Mallinckrodt

Generated: April 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 085937

« Back to Dashboard

NDA 085937 describes PENTOBARBITAL SODIUM, which is a drug marketed by Lannett, Vitarine, Whiteworth Town Plsn, Custopharm Inc, Elkins Sinn, Renaissance Ssa Llc, and Sagent Pharms, and is included in nine NDAs. It is available from two suppliers. Additional details are available on the PENTOBARBITAL SODIUM profile page.

The generic ingredient in PENTOBARBITAL SODIUM is pentobarbital sodium. There are two drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the pentobarbital sodium profile page.
Summary for 085937
Tradename:PENTOBARBITAL SODIUM
Applicant:Lannett
Ingredient:pentobarbital sodium
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:CAPSULE;ORALStrength50MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
US Army
Queensland Health
AstraZeneca
QuintilesIMS
Argus Health
Cipla
Merck
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.